Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches-Reference-Cited by-同舟云学术

Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches

Published:2016-10-07 Issue:31 Volume:22 Page:4807-4822
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Aimo Alberto,Borrelli Chiara,Vergaro Giuseppe,F. Piepoli Massimo,R. De Caterina Alberto,Mirizzi Gianluca,Valleggi Alessandro,Raglianti Valentina,Passino Claudio,Emdin Michele,Giannoni Alberto

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics;Journal of Translational Medicine;2023-12-07

2. M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics;2023-09-11

3. Identifying the Effect of Nuanxin Capsules on Myocardial Injury Induced by Chronic Hypoxia via Network Pharmacology Analysis and Experimental Validation;BioMed Research International;2022-10-04

4. Evaluation of the functional state of mitochondria isolated from mononuclear leukocytes by flow cytometry in patients with chronic heart failure receiving ubidecarenone;Bulletin of Siberian Medicine;2022-07-17

5. Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice;Drug Design, Development and Therapy;2022-04